| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 05/01/2007 | US7211562 cytotoxic agents followed by a heat shock protein 90 inhibitor, has a synergistic effect on the growth inhibition of cells; destroying cells having a cell proliferative disorder with wild-type retinoblastoma gene |
| 05/01/2007 | US7211424 Mammalian Subtilisin/kexin isozyme SKI-1: a proprotein convertase with a unique cleavage specificity |
| 05/01/2007 | US7211420 Oxidizing limonene or pinene or a cyclic sesquiterpene, wherein said limonene, pinene or cyclic sesquiterpene is optionally substituted by an alkyl of 1 to 6 carbons or an alkenyl of 1 to 6 carbons with a mutant haem-containing P450 enzyme, wherein mutant enzyme is a mutant of a P450BM-3 |
| 05/01/2007 | US7211399 Method for detecting leptin receptor ligands |
| 05/01/2007 | US7211398 Human genes and gene expression products: II |
| 05/01/2007 | US7211276 Method for preventing ulceration or irritation of mucosa |
| 05/01/2007 | US7211262 Burn pain treatment by peripheral administration of a neurotoxin |
| 05/01/2007 | US7211254 Nucleotide sequences coding interleukin-9 induced calcium activated chloride channel for use in identifying modulators for treatment and prevention of asthma, allergies and respiratory system disorders |
| 05/01/2007 | US7211252 Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists |
| 05/01/2007 | US7211246 Compositions comprising oestrone-3-0-sulphamate and trail (TNF-related apoptosis inducing ligand) |
| 05/01/2007 | CA2431397C Self emulsifying lipid matrix (selm) |
| 05/01/2007 | CA2392917C Pin1 as a marker for abnormal cell growth |
| 05/01/2007 | CA2366679C Stabilized oral pharmaceutical composition containing iodide and iodate and method |
| 05/01/2007 | CA2350794C Use of agonists of glucocorticosteroid receptors and/or mineral corticosteroid receptors, especially corticosteroids to treat addictions |
| 05/01/2007 | CA2320706C 20-hete antagonists and agonists |
| 05/01/2007 | CA2269594C Use of complexes for the preparation of compositions for the treatment of sensitive skin, preparation process and hypoallergenic compositions |
| 05/01/2007 | CA2249637C Uniform drug delivery therapy |
| 05/01/2007 | CA2148632C Topical medicament having cicatrizing activity |
| 04/26/2007 | WO2007047576A1 Pharmacological treatments for sleep disorders |
| 04/26/2007 | WO2007047327A2 Methods and articles for treating 25-hydroxyvitamin d insufficiency and deficiency |
| 04/26/2007 | WO2007047293A1 Adenosine a2a receptor antagonists for the treatment of extra-pyramidal syndrome and other movement disorders |
| 04/26/2007 | WO2007046544A1 Preparation for external application comprising salt of mast cell degranulation inhibitor having carboxyl group with organic amine |
| 04/26/2007 | WO2007046489A1 Therapeutic agent for heart disease |
| 04/26/2007 | WO2007046392A1 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 04/26/2007 | WO2007046347A1 Pharmaceutical for protection of motor nerve in patient with amyotrophic lateral sclerosis |
| 04/26/2007 | WO2007045689A2 Inhalatory pharmaceutical compositions in form of dry powders, solutions or suspensions |
| 04/26/2007 | WO2006128847A3 Medicament containing a betamimetic in conjunction with an anticholinergic and a pde iv inhibitor |
| 04/26/2007 | WO2006121560A8 Methods and compositions for treatment of cns disorders |
| 04/26/2007 | WO2006079999A3 Induction of a novel state of mind with a 5-ht2a agonist and a nmda antagonist |
| 04/26/2007 | US20070093518 Pharmaceutical compositions for the treatment of organophosphate poisoning |
| 04/26/2007 | US20070093507 Compositions comprising benzo (g) quinoline derivatives and prostaglandin derivatives |
| 04/26/2007 | US20070093495 Methods for treatment of parkinson's disease |
| 04/26/2007 | US20070093457 Compositions for treatment of cancer and inflammation with curcumin and at least one nsaid |
| 04/26/2007 | US20070093450 Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction |
| 04/26/2007 | US20070093446 Orally bioavailable compounds and methods for inhibiting platelet aggregation |
| 04/26/2007 | US20070093445 RNA interference mediating small RNA molecules |
| 04/26/2007 | US20070093419 Administering peptibodies, i.e., peptides fused to other molecules such as an Fc domain of an antibody, where the peptide moiety specifically binds to Ang-2 ( angiopoietin-2); antiinflammatory agent; antirheumatic agent |
| 04/26/2007 | US20070093418 Methods of treatment using specific binding agents of human angiopoietin-2 |
| 04/26/2007 | US20070092965 Isolating a mammalian conjunctival tissue explant in a growth medium until nodules form, allowing cells to grow; for treating lacerated corneas, ocular cicatricial pemphigoid, Steven Johnson syndrome, alkali burns and neurotrophic keratitis; kits for detecting mucin deficiency |
| 04/26/2007 | US20070092584 comprising a thiazolidinedione, one or more of chromium picolinate or chromium polynicotinate; bioavailable source of vanadium is vanadyl sulfate; synergistic mixture |
| 04/26/2007 | US20070092549 Delivering magnetic antimitotic agent in manner more toxic to cancer than normal cells while maintaining high concentration for a sustained period of time |
| 04/26/2007 | US20070092540 Carboxylate-gated-nitroxide (cgn) compounds and compositions and methods of use thereof |
| 04/26/2007 | US20070092523 Combination Therapy Of Respiratory Diseases Using Antibodies |
| 04/26/2007 | US20070092513 Antiproliferative agents; anticancer agents; controlling excessive proliferation or migration of smooth muscle cells by treating said smooth muscle cells with an effective amount of an antagonist of a native ErbB4 receptor |
| 04/26/2007 | US20070092504 Use of agents that modulate the interaction between PD-1 and its ligands in the downmodulation of immune responses |
| 04/26/2007 | US20070092466 in combination with carrier, and optionally activity enhancer; arresting or reversing hair loss, or both, and promoting hair growth; also a mascara; thickening and darkening hair |
| 04/26/2007 | CA2626688A1 Agents for treating cardiopathy |
| 04/26/2007 | CA2625859A1 Adenosine a2a receptor antagonists for the treatment of extra-pyramidal syndrome and other movement disorders |
| 04/26/2007 | CA2625416A1 Combination of a renin-inhibitor and an anti-dyslipidemic agent and/or an antiobesity agent |
| 04/26/2007 | CA2625341A1 Pharmaceutical for protection of motor nerve in patient with amyotrophic lateral sclerosis |
| 04/26/2007 | CA2625153A1 Modulation of neurogenesis by pde inhibition |
| 04/26/2007 | CA2624897A1 Methods and articles for treating 25-hydroxyvitamin d insufficiency and deficiency |
| 04/26/2007 | CA2624492A1 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 04/25/2007 | EP1777519A1 Bone morphogenic proteins (BMP), BMP receptors and BMP binding proteins and their use in the diagnosis and treatment of glaucoma |
| 04/25/2007 | EP1777234A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin - 2 |
| 04/25/2007 | EP1777225A1 Fused benzamide compound and vanilloid receptor 1 (vr1) activity inhibitor |
| 04/25/2007 | EP1777223A1 Indole derivatives useful as histamine H3 antagonists |
| 04/25/2007 | EP1776955A1 Method and composition for the treatment of lipid and glucose metabolism disorders |
| 04/25/2007 | EP1776954A2 The use of inhibitors of the renin-angiotensin system for the treatment of stroke |
| 04/25/2007 | EP1776950A1 Opioid formulations for treating pain |
| 04/25/2007 | EP1776948A1 Method of producing liposome-containing preparation |
| 04/25/2007 | EP1776128A1 Compositions for topical treatment |
| 04/25/2007 | EP1776105A2 Methods and compositions for inducing innate immune responses |
| 04/25/2007 | EP1776095A1 Pharmaceutical compositions comprising nep-inhibitors, inhibitors of the endogenous endothelin producing system and at1-receptor antagonists |
| 04/25/2007 | EP1539147A4 Methods of treating microbial infections in humans and animals |
| 04/25/2007 | EP1536845B1 Wound dressing materials comprising complexes of anionic polysaccharides with silver |
| 04/25/2007 | EP1476192B1 Methods and compositions for treating hyperproliferative conditions |
| 04/25/2007 | EP1425042B1 Complement pathway inhibitors binding to c5 and c5a without preventing the formation of c5b |
| 04/25/2007 | EP1309626B1 Cng2b: a putative human cyclic nucleotide-gated ion channel |
| 04/25/2007 | EP1259813B1 Diagnosis of malignant neoplasms |
| 04/25/2007 | EP1254174B1 Human cyr61 |
| 04/25/2007 | EP1128833B1 Use of agonists of corticosteroid receptors and a drug to treat addiction |
| 04/25/2007 | EP0949865A4 The use of cd4-binding small molecules to inhibit immune responses |
| 04/25/2007 | CN1953975A 2, 6 bisheteroaryl-4-aminopyrimidines as adenosine receptor antagonists |
| 04/25/2007 | CN1953769A Dietary supplement and method for treating digestive system-related disorders |
| 04/25/2007 | CN1953762A Sensitization to another anticancer therapy and/or amelioration of a side effect of another anitcancer therapy by treatment with a GST-activated anticancer compound |
| 04/25/2007 | CN1953758A 活性发泡体 Active foam |
| 04/25/2007 | CN1953756A Insulin resistance improving agent |
| 04/25/2007 | CN1953754A Peritoneal dialysis solution |
| 04/25/2007 | CN1953751A Combinations of substituted 1-phenyl-1,5-dihydro-pyrido- [3,2-b] indol-2-ones and other HIV inhibitors |
| 04/25/2007 | CN1953747A Diphenyl-indol-2-on compounds and their use in the treatment of cancer |
| 04/25/2007 | CN1953746A Methods of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of disorders of the central nervous system |
| 04/25/2007 | CN1953744A Combination of a DNA topoisomerase inhibitor and an IAP inhibitor |
| 04/25/2007 | CN1951961A Human Prox1 protein and its uses for resisting hepatitis B infection |
| 04/25/2007 | CN1951939A Novel pyrrole derivatives as pharmaceutical agents |
| 04/25/2007 | CN1951499A A cell mediated immunity vaccine and preparation method thereof |
| 04/25/2007 | CN1951498A A fibroid magnetic medicament and preparation method thereof |
| 04/25/2007 | CN1951497A Preparation of biological formulation for eliminating skin wrinkles |
| 04/25/2007 | CN1312165C Aryl 5-thio-beta-D-glucopyranoside derivatives and remedies for diabetes containing the same |
| 04/25/2007 | CN1311872C Anticancer combination of medication |
| 04/25/2007 | CN1311835C Pharmaceutical parenteral composition containing biphosphonate |
| 04/25/2007 | CN1311833C Inhibition of the growth factor dependency of tumor cells |
| 04/24/2007 | USRE39585 Administering streptococcus thermophilus in admixture withLactobacillus brevis, Lactobacillus acidophilus, Lactobacillus plantarum, Bifidobacterium infantis, Bifidobacterium longum or Bifidobacterium breve |
| 04/24/2007 | US7208582 Polynucleotides codes for antibodies having amino acid sequences selected from complementary determining regions of variable peptides or single chain fragments, used as anticarcinogenic agents |
| 04/24/2007 | US7208527 Potassium channel modulators |
| 04/24/2007 | US7208512 Benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma |
| 04/24/2007 | US7208508 Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and novel medicament combinations |
| 04/24/2007 | US7208501 Potent and long lasting antimuscarinic agents; respiratory, urological or gastrointestinal disorders |
| 04/24/2007 | US7208469 Administering adrenomedullin for stimulate chondrocyte proliferation; treatment of cartilage defects, bone disorders, growth disorders; biodrugs |
| 04/24/2007 | US7208180 Oral administration of a preparation having a) long chain polyunsaturated fatty acids, and b) specified phospholipids, and c) compounds that factor in methionine metabolism, such as folate, B vitamins, magnesium and zinc |